No Detail Found!

Clinical and microbiological characteristics of MRSA pneumonia in ICU patients and therapeutic effect of linezolid

Author(s)
Ren Hu Department of Blood Transfusion, Affiliated Hospital of Xuzhou Medical University,,China
Guang-zhen Liu Department of Pathology, Affiliated Hospital of Xuzhou Medical University,,China
Zhen Yan Department of Blood Transfusion, Affiliated Hospital of Xuzhou Medical University,,China
Abstract
The clinical and microbiological features of methicillin-resistant Staphylococcus aureus (MRSA) pneumonia among intensive care unit (ICU) patients were assessed in this study, as well as the relationship between linezolid treatment and outcomes. Of 282 ICU patients (January 2019-March 2024), 176 survived and 106 passed away. Independent predictors of death were age >60 years, tracheal intubation, central venous catheterization, =3 comorbidities and elevated procalcitonin (PCT). Seventy-two sputum representative MRSA isolates were analyzed for resistance determinants (mecA, SCCmec) and prevalent virulence genes (sea, hla,tsst-1,icaA,pvl). Linezolid therapy was associated with improved survival, reduced PCT levels and reduced prevalence of sea, tsst-1 and icaA. pvl co-presence with other virulence genes was related to poor outcomes. Including use of linezolid in predictive models improved discrimination (ROC AUC 0.805) .Transfusion recipients frequently present with independent risk factors associated with mortality in ICU patients diagnosed with MRSA pneumonia. Prognosis for ICU MRSA pneumonia is based on clinical risk factors, virulence gene carriage and transfusion status. Limitations are the retrospective study design and that sputum samples were used, which may result in misclassification.
Publication Details
Page(s) 2369-2378
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 6, Year: 2025

Request the full text from PASTIC

Keywords
clinical characteristics, virulence genes, Linezolid, ICU, MRSA pneumonia, Pvl
References
AbdAlhafiz AI,Elleboudy NS,Aboshanab KM,Aboulwafa MM,Hassouna NA .2023 .Phenotypic and genotypic characterization of linezolid resistance and the effect of antibiotic combinations on methicillinresistant Staphylococcus aureus clinical isolates. , 22(1) : 23.
Ali GH,Seiffein NL .2021 .Association of some virulence genes in methicillin resistant and methicillin sensitive Staphylococcus aureus infections isolated in community with special emphasis on pvl/mecA genes profiles in Alexandria, Egypt. Gene Rep, 25 : 101334.
Angioni D,Hites M,Jacobs F and De Breucker S M .2020 .Predictive factors of in-hospital mortality in older adults with community-acquired bloodstream infection. J. Frailty Aging, 9(4) : 232-7.
Cai X,Lin Y,Wu B,Luo Y,Li K Y .2025 .Sputum microbiota profiles of patients with rifampicin-resistant tuberculosis during the intensive-phase treatment. BMC Microbiol, 25 : 373.
Candel FJ,Salavert M,Estella A,Ferrer M,Ferrer R,Gamazo JJ,García-Vidal C,Del Castillo JG,GonzálezRamallo VJ,Miron-Rubio M .2023 .Ten issues to update in nosocomial or hospital-acquired pneumonia: An expert review. J. Clin. Med, 12(20) : 6526.
Chung H,Kim E,Yang E,Lee YW,Park JH,Bae S,Jung J,Kim MJ,Chong YP,Kim SH,Lee SO .2021 .Creactive protein predicts persistent bacteremia caused by community-acquired methicillin-resistant Staphylococcus aureus strain. Eur. J. Clin. Microbiol, 40(12) : 2497-504.
Cilloniz C,Dominedo C,Gabarrus A,Garcia-Vidal C,Becerril J,Tovar D,Moreno E,Pericas JM,Vargas CR,Torres A .2021 .Methicillin-susceptible Staphylococcus aureus in community-acquired pneumonia: risk factors and outcomes. J. Infect., 82(1) : 76-83.
Dennis LS,Daniel H,Harry L,John LH,Donald HB,Barry H,Linezolid MRSA Study Group H .2002 .Linezolid versus vancomycin for the treatment of methicillinresistant Staphylococcus aureus infections. Clin. Infect. Dis., 34(11) : 1481-90.
Duraiswamy S,Agarwalla S,Lok KS,Tse YY,Wu R,Wang Z R .2023 .A multiplex Taqman PCR assay for MRSA detection from whole blood. PLoS One, 18(11) : e0294782.
Eslami M,Safaripour A,Banihashemian SZ,Nikjoo Niaragh S,Hemmati MA,Shojaeian A,Fakhariyan S,Rabbani A,Oksenych V .2025 .Innovative antibiotic therapies for carbapenem-resistant gramnegative bacterial infections: Clinical efficacy, safety and comparative studies. Microorganisms, 13(2) : 295.
Gatti M,Viaggi B,Rossolini GM,Pea F,Viale P F .2023 .Targeted therapy of severe infections caused by Staphylococcus aureus in critically ill adult patients: A multidisciplinary proposal of therapeutic algorithms based on real-world evidence. , 11(2) : 394.
Guo LY,Yan SZ,Tao X,Yang Q,Li Q,Wang TS,Yu SQ,Chen SL .2020 .Evaluation of hypocrellin Aloaded lipase sensitive polymer micelles for intervening methicillin-resistant Staphylococcus aureus antibioticresistant bacterial infection. Mater Sci. Eng, 106 : 110230.
Hayakawa K,Yamaguchi T,Ono D,Suzuki H,Kamiyama J,Taguchi S,Kiyota K S .2020 .Two cases of intrafamilial transmission of community-acquired methicillin-resistant Staphylococcus aureus producing both PVL and TSST-1 causing fatal necrotizing pneumonia and sepsis. Infect. Drug Resist, 13 : 2921-7.
He H and Wunderink RG .2020 .Staphylococcus aureus pneumonia in the community. In Seminars in Respiratory and Critical Care Medicine, 41(04) : 470-479.
Hyun H,Song JY,Yoon JG,Seong H,Noh JY,Cheong HJ,Kim WJ .2022 .Risk factor-based analysis of community-acquired pneumonia, healthcare-associated pneumonia and hospital-acquired pneumonia: Microbiological distribution, antibiotic resistance and clinical outcomes. PLoS One, 17(6) : e0270261.
Ibrahim RA,Berhe N,Mekuria Z,Seyoum ET,BaladaLlasat JM,Abebe T,Mariam SH,Tsige E,Wang SH .2023 .Antimicrobial resistance and virulence gene profile of clinical Staphylococcus aureus: A multi-center study from Ethiopia. Infect Drug Resist. , 16 : 4835-44.
Ismael R,Alhameedawi AK,Abbas RS,Alsallameh S,Amer H,Firat M,Karkhane M M .2023 .Virulence genes and methicillin-resistant gene detection and antimicrobial resistance profiles isolated from different infection sites. Egypt Pharm. J., 22(2) : 265-71.
Jones BE,Ying J,Stevens V,Haroldsen C,He T,Nevers M,Christensen MA,Nelson RE,Stoddard GJ,Sauer BC,Yarbrough PM .2020 .Empirical anti-MRSA vs standard antibiotic therapy and risk of 30-day mortality in patients hospitalized for pneumonia. JAMA Intern. Med, 180(4) : 552-60.
Kawasuji H,Nagaoka K,Tsuji Y,Kimoto K,Takegoshi Y,Kaneda M,Murai Y,Karaushi H,Mitsutake K,Yamamoto Y .2023 .Effectiveness and safety of linezolid versus vancomycin, teicoplanin, or daptomycin against methicillin-resistant Staphylococcus aureus bacteremia: A systematic review and meta-analysis. Antibiotics., 12(4) : 697.
Kohno S,Yamaguchi K,Aikawa N,Sumiyama Y,Odagiri S,Aoki N,Niki Y,Watanabe S,Furue M,Ito T,Croos-Dabrera R .2007 .Linezolid versus vancomycin for the treatment of infections caused by methicillinresistant Staphylococcus aureus in Japan. , 60(6) : 1361-9.
Loaiza WM,Ruiz AK,Patiño CC,Vivas MC .2023 .Bacterial resistance in hospital-acquired infections acquired in the intensive care unit: A systematic review. Acta. Med, 66(1) : 1-10.
Ma A,Dong M,Cheng J,Liao X,Dong W,Liu C,Hu C,Yang J,Kang Y .2023 .Clinical efficacy and safety of linezolid in intensive care unit patients. J. Intensive Med, 3(1) : 65-72.
Moazen J,Zaniani FR,Asghar BH .2022 .Characterization of virulence genes and antibiotic resistance of methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-susceptible Staphylococcus aureus (MSSA) isolates in intensive care unit (ICU) and non-ICU wards. Trends Med. Sci., 2(2) : e129037.
Papan C,Schroder M,Hoffmann M,Knoll H,Last K,Albrecht F,Geisel J,Fink T,Gartner BC,Mellmann A,Volk T .2021 .Combined antibiotic stewardship and infection control measures to contain the spread of linezolid-resistant Staphylococcus epidermidis in an intensive care unit. Antimicrob. Resist Infect. Control., 10(1) : 99.
Peng Z,Zhou JA,Tian L JA .2020 .Pathogenic characteristics of sputum and bronchoalveolar lavage fluid samples from patients with lower respiratory tract infection in a large teaching hospital in China: A retrospective study. BMC Pulm. Med, 20(1) : 233.
Pichon M,Micaelo M,Rasoanandrasana S,Menn AM .2021 .Molecular characterization of Staphylococcus aureus isolates derived from severe pneumonia: A retrospective monocentre study. Infect Dis, 53(11) : 811-9.
Pickens CI,Wunderink RG .2022 .Methicillinresistant Staphylococcus aureus hospital-acquired pneumonia/ventilator-associated pneumonia. In Seminars Respir Crit. Care Med, 43(02) : 304-309.
Profir I,Popescu CM,Nechita A .2025 .Fatal influenza B-MRSA coinfection in a healthy adolescent: Necrotizing pneumonia, Cytokine storm and multiorgan failure. Children., 12(6) : 766.
Rao GG,Konicki R,Cattaneo D,Alffenaar JW,Marriott DJ,Neely M,IATDMCT Antimicrobial Scientific Committee M .2020 .Therapeutic drug monitoring can improve linezolid dosing regimens in current clinical practice: A review of linezolid pharmacokinetics and pharmacodynamics. , 42(1) : 83-92.
Rongrungruang Y,Plongla R,Pleumkanitkul S,Hantrakun V,Khawcharoenporn T .2025 .Etiology of hospitalacquired pneumonia (HAP) and ventilator-associated pneumonia (VAP) in tertiary-care hospitals in Thailand: A multicenter, retrospective cohort study. Infect. Drug Resist, 18 : 351-61.
Russo A,Salini S,Gava G,Merra G,Piccioni A,De Matteis G,Tullo G,Novelli A,Petrucci M,Gasbarrini A,Landi F A .2023 .Reduced prognostic role of serum PCT measurement in very frail older adults admitted to the emergency department. , 12(6) : 1036.
Schoevaerdts D,Sibille FX,Gavazzi G .2021 .Infections in the older population: What do we know?. Aging Clin. Exp. Res., 33(3) : 689-701.
Shi Y,Wu HL,Wu YH,Li S,Zhang LY,Xu SS,Huang HY,Zhang CH,Yu XB,Cai K,Zhang J .2023 .Safety and clinical efficacy of linezolid in children: A systematic review and meta-analysis. World J. Pediatr., 19(2) : 129-38.
Silva V,Almeida L,Gaio V,Cerca N,Manageiro V,Caniça M,Capelo JL,Igrejas G,Poeta P .2021 .Biofilm formation of multidrug-resistant MRSA strains isolated from different types of human infections. Pathogens., 10(8) : 970.
Solmaz I,Kalın BS .2021 .Assessment of antibiotic resistance of infectious agents in patients with pneumonia in tertiary critical care unit and effect on clinical outcomes. Int. J. Clin. Pract, 75(4) : e13872.
Touaitia R,Mairi A,Ibrahim NA,Basher NS,Idres T,Touati A .2025 .Staphylococcus aureus: A review of the pathogenesis and virulence mechanisms. , 14(5) : 470.
Vo-Pham-Minh T,Tran-Cong D,Phan-Viet H,Dinh-Chi T,Nguyen-Thi-Hong T,Cao-Thi-My T,Nguyen-ThiDieu H,Vo-Thai D,Nguyen-Thien V,Duong-Quy S .2024 .Staphylococcus aureus pneumonia in Can Tho, Vietnam: Clinical characteristics, antimicrobial resistance profile and risk factors of mortality. , 10(2) : 193-205.
Watkins RR,Lemonovich TL,File TM .2012 .An evidence-based review of linezolid for the treatment of methicillin-resistant Staphylococcus aureus (MRSA): Place in therapy. Core Evid, 7 : 131-43.
Yayan J,Ghebremedhin B,Rasche K B .2015 .No outbreak of vancomycin and linezolid resistance in Staphylococcal pneumonia over a 10-year period. PLoS One, 10(9) : e0138895.
Zou J,Xiao Y,Zhang L,Zuo Z,Wang X,Liao X,Cui N,Jin J,Qian Z,Wu A,Li C .2025 .Enhanced insights into immunity traits of elderly patients in the intensive care unit with infections: Evidence from a multicenter, prospective observational study. Crit. Care., 29(1) : 386.
0

Citations

0

Downloads

144

Views